Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)

This study has been completed.
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: June 1, 2007
Last updated: March 31, 2017
Last verified: March 2017
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 14, 2006
  Primary Completion Date: July 21, 2004 (Final data collection date for primary outcome measure)